Migraines are less common in people with diabetes

September 18, 2021

Two large studies have established that if you have diabetes you are less likely to suffer from migraines.

The first study was done on the entire population of Norway. The authors concluded that both type 1 and type 2 diabetes are significantly associated with a decreased risk of migraine.

The second study involved 74,247 French women. The researchers discovered that there was a lower risk of developing type 2 diabetes in women with active migraine. They also found that migraine was less common even prior to the development of diabetes.

Being overweight increases the frequency of migraines. Losing weight by any method, including bariatric surgery, improves migraines. There have been no studies of diabetes drugs in the treatment of migraines.

However, I do prescribe a diabetes drug metformin to migraine patients who are overweight or develop migraines when they are hungry. Metformin helps lose weight by maintaining a steady level of blood sugar. It does this by regulating the release of glucose from the liver. It also has anti-inflammatory properties.

Another diabetes drug, semaglutide in injections (Wegovy and Ozempic) and tablets (Rybelsus) is even more effective for weight reduction than metformin. Semaglutide, unlike metformin, is approved by the FDA for weight loss even in the absence of diabetes.

It is possible that the treatment of diabetes reduces the risk of developing migraines. The French study, however, suggests that other factors could play a role as well.

Written by
Alexander Mauskop, MD
Continue reading
April 10, 2026
Research
Migraines often strike on one side. Scientists say that matters more than we think
Migraines often strike on one side. Scientists say that matters more than we think New data may improve outcomes when we use TMS to treat migraines
Read article
March 26, 2026
Alternative Therapies
Lidocaine-Based Treatments Offer Another Option for Severe Migraines
This post explains how lidocaine, beyond its traditional use as a local anesthetic, can be given by IV or directly into the middle meningeal artery to help break severe, treatment-resistant migraines, with early studies showing promising relief and generally mild, manageable side effects.
Read article